US equities |
NVDA $238.90 ▲+2.12% SPCX $171.09 ▲+7.63% MU $1,063.96 ▼-1.02% TSLA $378.73 ▲+2.20% WBD $30.95 ▲+0.03% MSFT $525.18 ▲+1.48% AAPL $332.89 ▼-0.24% META $741.90 ▲+1.90%
FinancialContent

Kenvue Inc. Common Stock (NY:KVUE)

17.39 +0.19 (+1.10%)
Official Closing Price Updated: 4:10 PM EDT, Oct 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Kenvue Inc. Common Stock

< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
30 31 Next >
News headline image
KVUE DEADLINE TOMORROW: ROSEN, THE FIRST FILING FIRM, Encourages Kenvue Inc. Investors to Secure Counsel Before Important December 8 Deadline in Securities Class Action Commenced by the Firm – KVUE
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
KVUE DEADLINE TOMORROW: ROSEN, A LEADING LAW FIRM, Encourages Kenvue Inc. Investors to Secure Counsel Before Important December 8 Deadline in Securities Class Action Commenced by the Firm - KVUE
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Initial Public Offering Lawsuit
News headline image
Investing in the Aging Population: 3 Healthcare Stocks to Watch ↗
America is becoming a much older country on average. These three healthcare stocks are ideally positioned for this demographic shift. 
Via InvestorPlace
News headline image
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Kenvue Inc. (KVUE)
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
How To Earn $500 Per Month From (NYSE: KVUE) Kenvue Inc.'s Stock ↗
 
Via Benzinga
News headline image
KENVUE INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Kenvue To Contact Him Directly To Discuss Their Options
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
KENVUE DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Kenvue Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
News headline image
KENVUE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Kenvue Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
A Closer Look at Kenvue's Options Market Dynamics ↗
 
Via Benzinga
News headline image
KVUE DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Kenvue Inc. Investors to Secure Counsel Before Important December 8 Deadline in Securities Class Action Commenced by the Firm - KVUE
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Initial Public Offering Lawsuit
News headline image
Kenvue Inc. (NYSE: KVUE) Investor Notice: Deadline in Lawsuit on December 8, 2023 Coming Up ↗
San Diego, CA -- (SBWIRE) -- 12/05/2023 -- A deadline is coming up on December 8, 2023 in the lawsuit filed for certain investors of Kenvue Inc. (NYSE: KVUE). 
Via SBWire
Topics Lawsuit
News headline image
KVUE DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages Kenvue Inc. Investors to Secure Counsel Before Important December 8 Deadline in Securities Class Action Commenced by the Firm – KVUE
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
FINAL DEADLINE ALERT: Bernstein Liebhard LLP Reminds Kenvue Inc. Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
Spotlight on Kenvue: Analyzing the Surge in Options Activity ↗
 
Via Benzinga
News headline image
Looking Into Kenvue's Recent Short Interest ↗
 
Via Benzinga
News headline image
Dividend Kings In Focus: Kenvue ↗
Kenvue operates in the healthcare sector as a consumer products manufacturer. 
Via Talk Markets
News headline image
KVUE IMPORTANT DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages Kenvue Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm - KVUE
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Initial Public Offering Lawsuit
News headline image
KVUE DEADLINE ALERT: ROSEN, A LEADING LAW FIRM, Encourages Kenvue Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm - KVUE
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Initial Public Offering Lawsuit
News headline image
KVUE DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Kenvue Inc. Investors to Secure Counsel Before Important December 8 Deadline in Securities Class Action Commenced by the Firm - KVUE
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Initial Public Offering Lawsuit
News headline image
3 Cheap Dividend Stocks for December 2023 ↗
All three of these dividend stocks are trading at great valuations. 
Via The Motley Fool
News headline image
KENVUE SHAREHOLDER ALERT: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Kenvue To Contact Him Directly To Discuss Their Options
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
KVUE DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages Kenvue Inc. Investors to Secure Counsel Before Important December 8 Deadline in Securities Class Action Commenced by the Firm – KVUE
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
Johnson & Johnson Gets Analyst Upgrade Noting Bullish Pharma & MedTech Projections ↗
UBS has upgraded Johnson & Johnson (NYSE: JNJ), citing a bullish view of the company's pharmaceutical business and expectations for MedTech growth that align with the market, which is... 
Via Benzinga
News headline image
KVUE DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Kenvue Inc. Investors to Secure Counsel Before Important December 8 Deadline in Securities Class Action Commenced by the Firm - KVUE
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Initial Public Offering Lawsuit
News headline image
Wealth From Wellness: 7 Healthcare Stocks to Inoculate Your Portfolio ↗
Faced with a possible negative outcome in the market, these top healthcare stocks should offer the confidence you need. 
Via InvestorPlace
News headline image
KENVUE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Kenvue Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
KVUE DEADLINE ALERT: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Kenvue Inc. Investors to Secure Counsel Before Important December 8 Deadline in Securities Class Action First Filed by the Firm - KVUE
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Initial Public Offering Lawsuit
News headline image
Fresh on the Market: 3 Top Picks From the Renaissance IPO ETF ↗
There have not been many successful IPOs in 2023, so finding stock picks from the Renaissance IPO ETF won’t be easy. 
Via InvestorPlace
Topics ETFs Initial Public Offering
CLASS ACTION LAWSUIT FILED AGAINST KENVUE INC. (NYSE: KVUE)
--News Direct-- 
Via News Direct
Topics Lawsuit
News headline image
2023's most anticipated IPOs weren't always the big winners
146 U.S. companies went public in 2023, down 16.09% from last year. Despite market ups and downs, the Renaissance index of IPOs is outperforming the S&P 500 
Via MarketBeat
Topics ETFs Initial Public Offering Stocks
< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
30 31 Next >